Business Wire

Ace Metrix Congratulates Cannes Creative Effectiveness Lions Winners, Revealing Ace Scores and Consumer Feedback for Campaigns that Aired in the U.S.

20.6.2012 01:20:25 CEST | Business Wire | Press release

Share
CA-ACE-METRIX

Ace Metrix™, the new standard in television and video analytics, congratulates the Cannes Creative Effectiveness Lions Winners and announces the Ace Scores of the winners, including Grand Prix Winner Axe/ Unilever, as well as other Lions winners Chrysler, Snickers/ Mars and Febreze/ P&G. Ads may be viewed here .

Cannes Lions Creative Effectiveness Winners

Brand         Campaign         Average Ace Score
Axe (Grand Prix Winner)         “Excite”        

607**

Snickers         “You’re Not You When You’re Hungry”         633
Chrysler         “Born of Fire”         591
Febreze         “Breathe Happy”         601

Definition: Ace Score is the measure of ad creative effectiveness based on viewer reaction to national TV ads. Respondents are randomly selected and representative of the U.S. TV viewing audience. The results are presented on a scale of 0-950, which represents scoring on creative attributes such as relevance, persuasion, watchability, information, attention, etc.

**Ace Score for 16-20 year-old males, target audience.

“We are true believers in the power of great creative—Axe’s Excite/ Angels campaign by BBH London was created to win the hearts and minds of young men—an objective it achieved in spades, as its exceedingly high attention and desire scores indicate,” said Peter Daboll, CEO of Ace Metrix. “Snickers’ ‘You’re Not You When You’re Hungry,’ campaign by Abbott Mead Vickers BBDO achieved an average Ace Score of 633, and worked well because it wove its celebrity stars, including Betty White, Rosanne Barr and Richard Lewis and Liza Minelli, into the storyline of the ads.”

Proctor & Gamble’s Febreze brand made a huge splash at this year’s Cannes, with an average Ace Score of 601 for its “Breathe Happy” campaign by Grey. The 60-second kick-off ad for the campaign, featuring Susan and Erica sitting on a filthy couch, scored a successful 619. Verbatim comments from consumers indicated that they were able to truly understand the effectiveness of Febreze from the demonstrable nature of the ads. One Midwest male said, “I think it made a lasting point. I thought it was hilarious and extremely entertaining.” One mother from the West said, “I thought it was a great commercial. I liked the demonstration of it. I thought it was informative and also funny.”

Chrysler and Wieden + Kennedy’s “Born of Fire” campaign starring Eminem, which broke during the 2011 Super Bowl, achieved a 591 Ace Score, exceeding the automotive average of 526. The ad appealed to Americans’ sense of patriotism, as evidenced by comments from this 36-49 year-old father in the south, “An awesome commercial—so glad the United States still has a hold on luxury vehicles--gives the feeling that purchasing a vehicle here will directly impact our lives as Americans and the economy.

All U.S. ads can be viewed at https://www.acemetrix.com/spotlights/events/cannes-2012/ .

About Ace Metrix

Ace Metrix is the new standard in television analytics, dedicated to delivering better, faster, and more cost-effective solutions for evaluating video advertising within competitive context. Through the Ace Metrix LIVE™ platform, companies can now access timely, actionable data wherever, whenever they need to, enabling real-time advertising campaign optimization. Combining leading edge technology and patent pending methodology, Ace Metrix is revolutionizing the way marketers measure themselves and their competitive landscape. The company is privately held and is backed by leading venture capital firms and industry leaders including Hummer Winblad Venture Partners, Palomar Ventures, Leapfrog Ventures, and WPP.

Note: Ace Metrix is not an official sponsor of the Cannes Lions festival nor does it participate in the selection, evaluation, or judging process.

Follow Ace Metrix on Facebook at AceMetrixInc and on twitter at No. Ace_Metrix.

Ace Metrix, Ace Metrix LIVE™, Ace Metrix PRE™, Ace Metrix MOBILE™, Ace Metrix TARGET™, and the Ace Score™, and their logo designs are trademarks of Ace Metrix, Inc. All rights reserved.

Contact:

For Ace Metrix
Michelle Robertson, 646-279-5775
michelle@kerlancomm.com

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

SINOVAC Regained Compliance With the Nasdaq Global Market’s Listing Requirements15.6.2026 12:00:00 CEST | Press release

Sinovac Biotech Ltd. (Nasdaq: SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated June 10, 2026 (the "Notification Letter"), from Hearing Advisor of The Nasdaq Stock Market LLC., indicating that the Company has regained compliance with Listing Rule 5250(c)(1) and that the Company is therefore in compliance with the Nasdaq Global Market's listing requirements. As noted in the Hearing Panel's May 20, 2026 compliance determination, the Company remains under a Mandatory Panel Monitor pursuant to Listing Rule 5815(d)(4)(B) until May 20, 2027. The Company filed its annual report on Form 20-F for the year ended December 31, 2025 on June 5, 2026. The Notification Letter also stated that the hearing before the Hearings Panel, applied for by the Company, had accordingly been canceled. About SINOVAC Sinovac Biotech Ltd. (SINOVAC) is a China-based global biopharmaceutical company, with a mission

KRM22 partners with Sigma AI to enhance market surveillance and risk intelligence capabilities15.6.2026 12:00:00 CEST | Press release

KRM22, the technology and software investment company focused on risk management solutions for capital markets, today announced a strategic partnership with Sigma AI, a leading provider of AI-driven financial insights, to integrate advanced news sentiment analytics into its risk management application suite. The integration marks a significant enhancement to KRM22’s capabilities, enabling clients to incorporate real-time market sentiment insights derived from global news sources directly into their risk frameworks. By leveraging Sigma AI’s proprietary natural language processing and machine learning models, KRM22 will help firms better identify emerging risks, anticipate market-moving events, and make more informed trading and compliance decisions. Advancing risk management through AI-driven sentiment analysis As part of the first phase of the collaboration, KRM22 will embed Sigma AI’s news sentiment engine within its application suite. This will provide users with actionable intellige

HUI (HUI:VSE) Merges Traditional and Crypto Finance: Commences Continuous Trading in Vienna With Leading Market Maker and Announces Impending Token Listing on Major Global Exchange15.6.2026 11:15:00 CEST | Press release

The first SaaS SuperApp for startups and VCs capitalizes on a $25M round a from Nimbus Capital and a +15% stock surge, unveiling a v3/v4 roadmap that bridges public equity with digital asset liquidity. HUI S.p.A., the pioneering vertical SuperApp and SaaS company dedicated to the global Venture Capital and startup ecosystem listed on the Vienna Stock Exchange, today released its global product strategy, marking an unprecedented convergence between traditional regulated markets and decentralized finance. Driven by a +15% stock surge and the consolidation of its $25 million round a equity commitment fully subscribed by global institutional fund Nimbus Capital, the company announced its upcoming transition to continuous trading on the Vienna market in partnership with a leading European market maker, alongside the activation of the initial PUT options tied to the round. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/2026061293689

Syngenta Signs MoU to Be Strategic Partner in India’s First Open-Data Agricultural Ecosystem Annam.AI15.6.2026 09:35:00 CEST | Press release

Agricultural innovation leader to contribute with agronomic expertise in building accurate crop health, pest forecasting and heat stress models India’s agriculture sector is a global powerhouse, uniquely characterized by its massive scale, vast arable land, diverse agro-climatic zones and rich biodiversity. These strengths have propelled the country to become one of the world’s leading producers of crops such as rice and wheat. However, farmers in the country face significant challenges – from erratic monsoons, severe droughts and unseasonal rains compounded by El Nino, to pests and diseases that destroy an estimated 30 percent of crops annually. More than 80 percent of India’s estimated 150 million farming households are composed of smallholder farmers who operate on less than two hectares of land. This limits economies of scale, sets obstacles to the wider adoption of advanced technologies and could widen a systemic gap between large commercial agricultural operations and the bulk of

Pelago Bioscience Acquires RG Discovery, Forming an Integrated Drug Discovery Partner Spanning Biology and Chemistry15.6.2026 09:00:00 CEST | Press release

The combination unites Pelago Bioscience’s industry-leading and proprietary cellular target engagement capabilities with RG Discovery’s deep medicinal chemistry and custom synthesis expertise - enabling customers to advance drug discovery programs across the full design-make-test-analyze-(DMTA) cycle with a single specialist partner. Pelago Bioscience, a specialist drug discovery focused contract research organization (CRO), known for its industry-leading cell-based target engagement assays, is pleased to announce the acquisition of RG Discovery, and thereby adding deep expertise in medicinal chemistry, custom synthesis, and integrated drug discovery. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260615340933/en/ Michael Dabrowski, Chief Executive Officer of Pelago Bioscience By combining Pelago Bioscience's biology-focused capabilities with RG Discovery's chemistry expertise, the enlarged platform will enable drug discover

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye